Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIPIFARNIB for Chronic myeloid leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where TIPIFARNIB was used for Chronic myeloid leukaemia.

Most Reported Side Effects for TIPIFARNIB

Side Effect Reports % Deaths Hosp.
Treatment failure 8 32.0% 1 0
Thrombocytopenia 5 20.0% 2 1

Other Indications for TIPIFARNIB

Breast cancer metastatic (5)

Other Drugs Used for Chronic myeloid leukaemia

IMATINIB (18,795) DASATINIB (15,612) NILOTINIB (14,842) PONATINIB (4,723) BOSUTINIB (4,231) ASCIMINIB (1,377) GLIVEC (636) TASIGNA (562) OMACETAXINE MEPESUCCINATE (500) HYDROXYUREA (457)

Related Pages

TIPIFARNIB Full Profile All Chronic myeloid leukaemia Drugs TIPIFARNIB Demographics TIPIFARNIB Timeline